Prepare for your visit

Desmond James Young

Pulmonary Disease · Murrells Inlet, SC · NPI 1760425532

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$20,660.74

in general payments reported to CMS, 2019-2025 · $10K in 2025

The $10K reported for 2025 was more than what 93% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

Who reported paying

General payments only, top 6 by amount.

Verona Pharma, INC. $8,609.93
Glaxosmithkline, LLC. $2,310.21
Astrazeneca Pharmaceuticals LP $1,407.74
Insmed, INC. $819.04
Regeneron Healthcare Solutions, INC. $768.28
Boehringer Ingelheim Pharmaceuticals, INC. $746.06

Drugs and devices associated with these payments

Ohtuvayre Dupixent Trelegy Ellipta Smartvest Tezspire Airsupra Fasenra Tyvaso Arikayce Breztri Sunosi Nucala

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Desmond Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/34046/desmond-james-young